“Evaluating the safety and efficacy of aminolevulinic acid 20% topical solution activated by blue light in the treatment of facial cutaneous squamous cell carcinoma in situ”, J of Skin, vol. 8, no. 6, p. s483, Nov. 2024, doi: 10.25251/skin.8.supp.483.